• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定并验证 SAA 作为一种潜在的肺癌生物标志物及其在肺癌转移发病机制中的作用。

Identification and validation of SAA as a potential lung cancer biomarker and its involvement in metastatic pathogenesis of lung cancer.

机构信息

Department of Biochemistry, School of Dentistry and Brain Korea 21, Kyungpook National University and ProtAnBio, Daegu, South Korea.

出版信息

J Proteome Res. 2011 Mar 4;10(3):1383-95. doi: 10.1021/pr101154j. Epub 2011 Jan 25.

DOI:10.1021/pr101154j
PMID:21141971
Abstract

Lung cancer is recently regarded as an overhealed inflammatory disease. Serum amyloid A (SAA) is known as an acute phase protein, but it is likely involved in the cancer pathogenesis. We identified both SAA1 and SAA2 in the pooled sera of lung cancer patients but not in the healthy control, by LC-MS/MS analysis. We found that about 14-fold higher levels of SAA in lung cancer patients' sera and plasma compared to healthy controls by ELISA using total 350 samples (13.89 ± 37.18 vs 190.49 ± 234.70 ug/mL). The SAA levels were also significantly higher than in other pulmonary disease or other cancers. An immunohistochemical study using tissue microarray showed that, unlike other cancer tissues, lung cancer tissues highly express SAA. Further in vitro experiments showed that SAA is induced from lung cancer cells by the interaction with THP-1 monocytes and this, in return, induces MMP-9 from THP-1. In in vivo animal models, overexpressed SAA promoted Lewis lung carcinoma (LLC) cells to metastasize and colonize in the lung. Our data suggest that a higher concentration of SAA can serve as an indicator of lung adenocarcinoma and represents a therapeutic target for the inhibition of lung cancer metastasis.

摘要

肺癌最近被认为是一种过度愈合的炎症性疾病。血清淀粉样蛋白 A(SAA)是一种急性期蛋白,但它可能参与了癌症的发病机制。通过 LC-MS/MS 分析,我们在肺癌患者的混合血清中鉴定出 SAA1 和 SAA2,但在健康对照组中没有。我们发现,通过 ELISA 分析 350 例样本,肺癌患者血清和血浆中的 SAA 水平比健康对照组高约 14 倍(13.89±37.18 vs 190.49±234.70 ug/mL)。SAA 水平也明显高于其他肺部疾病或其他癌症。使用组织微阵列的免疫组织化学研究表明,与其他癌症组织不同,肺癌组织高度表达 SAA。进一步的体外实验表明,SAA 是由肺癌细胞与 THP-1 单核细胞相互作用诱导产生的,而这反过来又会诱导 THP-1 产生 MMP-9。在体内动物模型中,过表达的 SAA 促进 Lewis 肺癌(LLC)细胞转移并在肺部定植。我们的数据表明,较高浓度的 SAA 可以作为肺腺癌的指标,并代表抑制肺癌转移的治疗靶点。

相似文献

1
Identification and validation of SAA as a potential lung cancer biomarker and its involvement in metastatic pathogenesis of lung cancer.鉴定并验证 SAA 作为一种潜在的肺癌生物标志物及其在肺癌转移发病机制中的作用。
J Proteome Res. 2011 Mar 4;10(3):1383-95. doi: 10.1021/pr101154j. Epub 2011 Jan 25.
2
Progression of non-small cell lung cancer: diagnostic and prognostic utility of matrix metalloproteinase-2, C-reactive protein and serum amyloid A.非小细胞肺癌的进展:基质金属蛋白酶-2、C 反应蛋白和血清淀粉样蛋白 A 的诊断和预后效用。
Oncol Rep. 2013 Feb;29(2):469-73. doi: 10.3892/or.2012.2123. Epub 2012 Nov 5.
3
Elevated levels of the acute-phase serum amyloid are associated with heightened lung cancer risk.血清淀粉样蛋白 A 水平升高与肺癌风险增加有关。
Cancer. 2010 Mar 1;116(5):1326-35. doi: 10.1002/cncr.24868.
4
Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS.通过多凝集素亲和色谱法和液相色谱-串联质谱法鉴定人肺腺癌潜在血清糖蛋白生物标志物
Proteomics. 2007 Dec;7(23):4292-302. doi: 10.1002/pmic.200700433.
5
The Haptoglobin β chain as a supportive biomarker for human lung cancers.触珠蛋白β链作为人类肺癌的一种辅助生物标志物。
Mol Biosyst. 2011 Apr;7(4):1167-75. doi: 10.1039/c0mb00242a. Epub 2011 Jan 21.
6
Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.肺癌中血清基质金属蛋白酶-2、-9及金属蛋白酶组织抑制剂-1、-2——TIMP-1作为一种预后标志物
Anticancer Res. 2000 Mar-Apr;20(2B):1311-6.
7
Large-scale isotype-specific quantification of Serum amyloid A 1/2 by multiple reaction monitoring in crude sera.采用多重反应监测技术对粗血清中的血清淀粉样蛋白 A1/2 进行大规模同型特异性定量分析。
J Proteomics. 2012 Apr 3;75(7):2170-80. doi: 10.1016/j.jprot.2012.01.018. Epub 2012 Jan 26.
8
Clinical utility of serum amyloid A and macrophage migration inhibitory factor as serum biomarkers for the detection of nonsmall cell lung carcinoma.血清淀粉样蛋白A和巨噬细胞移动抑制因子作为检测非小细胞肺癌血清生物标志物的临床应用价值。
Cancer. 2004 Jul 15;101(2):379-84. doi: 10.1002/cncr.20377.
9
Evaluation of serum amyloid A as a biomarker for gastric cancer.血清淀粉样蛋白A作为胃癌生物标志物的评估。
Ann Surg Oncol. 2007 Jan;14(1):84-93. doi: 10.1245/s10434-006-9091-z. Epub 2006 Oct 25.
10
[Identification and clinical evaluation of lung cancer serum biomarker L-lactate dehydrogenase B].肺癌血清生物标志物L-乳酸脱氢酶B的鉴定与临床评估
Zhonghua Jie He He Hu Xi Za Zhi. 2007 Aug;30(8):577-81.

引用本文的文献

1
High-density lipoproteins. Part 2. Impact of disease states on functionality.高密度脂蛋白。第2部分。疾病状态对功能的影响。
Am J Prev Cardiol. 2025 Aug 7;23:101073. doi: 10.1016/j.ajpc.2025.101073. eCollection 2025 Sep.
2
Dissecting the role of inflammatory biomarkers in breast cancer: Insights from Mendelian randomization.剖析炎症生物标志物在乳腺癌中的作用:孟德尔随机化研究的见解
Medicine (Baltimore). 2025 Aug 15;104(33):e43732. doi: 10.1097/MD.0000000000043732.
3
Liquid biopsy in cancer current: status, challenges and future prospects.
癌症液体活检的现状、挑战与未来前景
Signal Transduct Target Ther. 2024 Dec 2;9(1):336. doi: 10.1038/s41392-024-02021-w.
4
Research progress of biomarkers in evaluating the severity and prognostic value of severe pneumonia in children.生物标志物在评估儿童重症肺炎严重程度及预后价值中的研究进展
Front Pediatr. 2024 Oct 1;12:1417644. doi: 10.3389/fped.2024.1417644. eCollection 2024.
5
Contribution of crosstalk of mesothelial and tumoral epithelial cells in pleural metastasis of lung cancer.间皮细胞与肿瘤上皮细胞的相互作用在肺癌胸膜转移中的作用
Transl Lung Cancer Res. 2024 May 31;13(5):965-985. doi: 10.21037/tlcr-24-118. Epub 2024 May 29.
6
Diagnostic and Prognostic Significance of Serum Biomarkers - Serum Amyloid A and CYFRA 21-1 in Lung Cancer.血清生物标志物——血清淀粉样蛋白A和细胞角蛋白19片段在肺癌中的诊断及预后意义
Int J Appl Basic Med Res. 2023 Apr-Jun;13(2):89-94. doi: 10.4103/ijabmr.ijabmr_639_22. Epub 2023 Jul 17.
7
Emerging Biosensing Methods to Monitor Lung Cancer Biomarkers in Biological Samples: A Comprehensive Review.用于监测生物样品中肺癌生物标志物的新兴生物传感方法:综述
Cancers (Basel). 2023 Jun 29;15(13):3414. doi: 10.3390/cancers15133414.
8
Liquid Biopsy for Lung Cancer: Up-to-Date and Perspectives for Screening Programs.液体活检在肺癌中的应用:筛查项目的最新进展和展望。
Int J Mol Sci. 2023 Jan 28;24(3):2505. doi: 10.3390/ijms24032505.
9
Plasma Proteomics Enable Differentiation of Lung Adenocarcinoma from Chronic Obstructive Pulmonary Disease (COPD).血浆蛋白质组学可区分肺腺癌与慢性阻塞性肺疾病(COPD)。
Int J Mol Sci. 2022 Sep 24;23(19):11242. doi: 10.3390/ijms231911242.
10
Interaction between BEND5 and RBPJ suppresses breast cancer growth and metastasis via inhibiting Notch signaling.BEND5 与 RBPJ 的相互作用通过抑制 Notch 信号通路抑制乳腺癌的生长和转移。
Int J Biol Sci. 2022 Jun 27;18(10):4233-4244. doi: 10.7150/ijbs.70866. eCollection 2022.